10.1002/cne.22093 J
Caution in patients with kidney disease, liver disease, urinary retention, enlarged prostate, or elderly patients due to possible increased risk of side effects
Although its blood pressure-lowering effects appear to be less than spironalactone and eplerenone (both steroidal mineralocorticoid receptor antagonists), this drug has impressive benefits in the setting of DKD
Your body makes it naturally in your small intestine after you eat
Beyond Metabolism: Emerging Research Recent studies suggest GLP-1 may have cardiovascular protective effects and potential neuroprotective properties, though these areas remain under active investigation 4 Nauck, M.A
[88] For Suspected Digestive Enzyme Deficiencies Constipation can be the result of not having enough digestive enzymes to break down the food we eat, and low digestive enzymes can be the result of dysbiosis